Similar Articles
Complementary-Alternative Medicine in Rheumatoid Arthritis
Demirhan Dıraçoğlu
The Use of Complementary and Alternative Medicine in Turkish Patients with Rheumatic Diseases
Hasan ULUSOY, Tülün Kaya GÜÇER, Murat AKSU, Şule ARSLAN, Abdülkadir HABİBOĞLU, Gürkan AKGÖL, Ayhan BİLGİCİ, Ömer KURU, İlhan ÇETİN, Ayhan KAMANLI, Salih ÖZGÖÇMEN
DOI: 10.5606/tjr.2012.004
The Correlation Between the Molecular Heterogeneity of Prolactin and Autoantibody and Complement Levels in Patients with Systemic Lupus Erythematosus
Kusworini HANDONO, Olivia ANGGRAENY, Catur Suci SUTRISNANI, Ermin RACHMAWATI, Agustina Tri ENDHARTI, Maimun Zulbaidah ARTHAMIN
DOI: 10.5606/tjr.2014.3832
Childhood-Onset Systemic Lupus Erythematosus in Southwestern Iran: A Clinical and Serological Study
Soheila ALYASIN, Reza AMIN, Mozhgan MOGHTADERI, Sara KASHEF,1,2
DOI: 10.5606/tjr.2014.3817
Primary Axillary Lipogranuloma in a Patient With Systemic Lupus Erythematosus
Suk Jung Kim
DOI: 10.5606/ArchRheumatol.2014.3662
Interleukin-18 as a Biomarker of Subclinical Lupus Nephritis
Samah Abdel Rahman EL BAKRY, AbdelAzim Mohamed ALHEFNY, Dina Shawky AL-ZIFZAF, Ola Hasan NADA, Rania Hamdy EL KABARITY, Khaled OMAR
DOI: 10.5606/ArchRheumatol.2015.4675
Up-regulated Complement 3 Production by Toll-like receptor 9/ Transforming Growth Factor-Beta 1/Complement 3 Pathway in Whole Blood Cells of Lupus Thrombocytopenia
Yi YUAN, Ling ZHAO, Ning MA, Zhuang YE, Zhenyu JIANG, Congqiu CHU
DOI: 10.5606/ArchRheumatol.2017.6279
Autoimmune Manifestations in Heterozygote Type I Complement 2 Deficiency: A Child Eventually Diagnosed With Systemic Lupus Erythematosus
Rabia Miray KIŞLA EKİNCİ, Sibel BALCI, Atil BİŞGİN, Bahriye ATMIŞ, Dilek DOĞRUEL, Mustafa YILMAZ
DOI: 10.5606/ArchRheumatol.2019.6910
Coexistence of Juvenile Systemic Lupus Erythematosus and Juvenile Spondyloarthropathy: A Case Report and Review of the Literature
Ayşe TANATAR, Ummihan TOPAL, Şerife GÜL KARADAĞ, Hafize Emine SÖNMEZ, Nuray AKTAY AYAZ
DOI: 10.5606/ArchRheumatol.2020.7468
Predictors of renal and patient outcomes in anti-neutrophil cytoplasmic antibody-associated vasculitis: Our single-center, tertiary care experience
Aysun Toraman, Özgül Soysal Gündüz
DOI: 10.46497/ArchRheumatol.2021.8687
Clinical study of factors associated with pregnancy outcomes in pregnant women with systemic lupus erythematosus in the southern China
Ke Zhang, Chunmei He, Qiaoting Deng, Wengen Li, Zhixiong Zhong, Jingyuan Hou
DOI: 10.46497/ArchRheumatol.2022.8870
Evaluation of personality disorders using the structured clinical interview for DSM-5 personality disorders, quality of life, and disease activity in patients with systemic lupus erythematosus
Yunus Durmaz, İlker İlhanlı, Pınar Durmaz
DOI: 10.46497/ArchRheumatol.2022.9002
Pregnancy outcomes between pregnant systemic lupus erythematosus patients with clinical remission and those with low disease activity: A comparative study
Worawit Louthrenoo, Thananant Trongkamolthum, Nuntana Kasitanon, Antika Wongthanee
DOI: 10.46497/ArchRheumatol.2022.9140
Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients
Eman Eissa, Botros Morcos, Dalia Dorgham, Naglaa Kholoussi
DOI: 10.46497/ArchRheumatol.2022.9217
MT-CO1 expression in nine organs and tissues of different-aged MRL/lpr mice: Investigation of mitochondrial respiratory chain dysfunction at organ level in systemic lupus erythematosus pathogenesis
Xinglan Huang, Peng Yan, Xinghua Song, Suiying Zhang, Yuqiong Deng, Caifeng Huang, Xiaoqing Zhao, Sheng Liu, Xiping Cheng, Dongjiang Liao
DOI: 10.46497/ArchRheumatol.2022.9168
Identification of a novel mutation in complement receptor 2 in Chinese familial systemic lupus erythematosus
Yuewu Tang, Yi Luo
DOI: 10.46497/ArchRheumatol.2022.9167
Pro-apoptotic Bax mRNA expression: A novel predictor for systemic lupus erythematosus disease flare-up
Rasha N Yousef, Abeer Ramadan, Eman Awadallah, Alshaimaa R Alnaggar, Noha M Khalil, Mervat E.Behiry, Asmaa Ali, Hesham Gamal El Dine
DOI: 10.46497/ArchRheumatol.2023.9448
The ABCs of antiphospholipid syndrome
Ayşe Bahar Keleşoğlu Dinçer, Doruk Erkan
DOI: 10.46497/ArchRheumatol.2023.41875
Association between levels of serum and urinary B cell-activating factor and systemic lupus erythematosus disease activity
Maryam Rezazadeh, Mohammad Hasan Jokar, Seyedeh Mehrnaz Aghili, Zahra Mirfeizi, Mahmoud Mahmoudi, Negar Morovatdar, Kamila Hashemzadeh
DOI: 10.46497/ArchRheumatol.2023.9549
Mortality in a cohort of Egyptian systemic lupus erythematosus patients: A comparison with African, Arabic, and Mediterranean studies
Sherif Gamal, Hanaa Rady, Nesreen Sobhy, Ibrahem Siam, Ahmed Soliman, Fatema Elgengehy
DOI: 10.46497/ArchRheumatol.2023.9860